Product Details
Enspryng Satralizumab*
Satralizumab120 mg
Injection
ROA
Intramuscular
Applicant Name
Roche Products Limited
NRN
A6-100128
Status
Active
Composition
ATC Code
L04AC19
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
1 X 1
Product Description
4 NF-BV-277244 Enspryng Satralizumab Satralizumab 120mg, L-Histidine3.1 mg, L-Aspartic Acid q.s. to pH 6.0, L-Arginine 26.1 mg, Poloxamer 188 0.5 mg, Water for injection q.s. to 1 mL. Vaccines & Biologicals Biologics Imported Products 1*1pack 2/20/2023 ROCHE PRODUCTS LIMITED, 2nd Floor, 48/50 Isaac John Street Ikeja GRA, Lagos. 8056292219 angela.essien@roche.com Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant, Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant 16-3 Kiyoharakogyo-danchi, Utsunomiya-city 321-3231 Tochigi Japan, Japan NF-BV-277244 Enspryng A6-100128 Satralizumab Vaccines & Biologicals 1*1pack N/A 1 ml solution in a PFS (polymer) with a staked-in, stainless steel needle, fitted with a chlorinated butyl rubber-polypropylene rigid needle shield a INJECTION ROCHE PRODUCTS LIMITED 8056292219 angela.essien@roche.com & 9TH FLOOR, MOBOLAJI BANK ANTHONY IKEJA LAGOS Imported Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant *New Product Registration
Manufacturer Name
Chugai Pharma Manufacturing Co. Ltd Utsunomiya Plant
Manufacturer Country
JAPAN
Approval Date
2023-08-23
Expiry Date
2028-08-22